A novel method for the production of crystalline micronised particles

International Journal of Pharmaceutics

Volumn 388, Issue 1-2, 2010, Pages 114-122

  Muhammad, Syed Anuar Faua'ad Syed ^a,b   Langrish, Tim ^a   Tang, Patricia ^a   Adi, Handoko ^a   Chan, Hak Kim ^a   Kazarian, Sergei G ^c   Dehghani, Fariba ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITI TEKNOLOGI MALAYSIA   (Malaysia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Crystallisation; Inhalation drug delivery; Menthol; Salbutamol sulphate; Supercritical CO2

Indexed keywords

CARBON DIOXIDE; SALBUTAMOL SULFATE;

AEROSOL; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; GAS CHROMATOGRAPHY; NANOTECHNOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER; PRESSURE; PRIORITY JOURNAL; TEMPERATURE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ALBUTEROL; CARBON DIOXIDE; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; DRUG STABILITY; MENTHOL; PARTICLE SIZE; SURFACE PROPERTIES; TEMPERATURE; TIME FACTORS; WATER;

EID: 76649107346     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.12.047     Document Type: Article

References (50)

1. Brodka-Pfeiffer K., Langguth P., Grab P., and Hausler H. Influence of mechanical activation on the physical stability of salbutamol sulphate. Eur. J. Pharm. Biopharm. 56 (2003) 393-400
2. Brown, A.B., Ferriter, M.S. Oort, M.M.V., 2003, Pharmaceutical Products and Methods of Manufacture Patent. WIP Organization WO 03/099290 A1 (04 December).
3. Buckton G., Darcy P., Greenleaf D., and Holbrook P. The use of isothermal microcalorimetry in the study of change in crystallinity of spray-dried salbutamol sulphate. Int. J. Pharm. 116 (1995) 113-118
4. Celebi N., Erden N., and Turkyilmaz A. The preparation and evaluation of salbutamol sulphate containing poly(lactic acid-co-glycolic acid) microspheres with factorial design-based studies. Int. J. Pharm. 136 (1996) 89-100
5. Chan H.K. Inhalation drug delivery devices and emerging technologies. Expert Opin. Ther. Pat. 13 (2003) 1333-1343
6. Chan H.-K., and Chew N.Y.K. Novel alternative methods for the delivery of drugs for the treatment of asthma. Adv. Drug Deliv. Rev. 55 (2003) 793-805
7. Chawla A., Taylor K.M.G., Newton J.W., and Jhonson M.C.R. Production of spray dried salbutamol sulphate for use on dry aerosol formulation. Int. J. Pharm. 108 (1994) 233-240
8. Chen Z., Sheng P., Weitz D.A., Lindsay H.M., Lin M.Y., and Meakin P. Optical properties of aggregate clusters. Phys. Rev. B 37 (1988) 5232-5235
9. Chew N.Y.K., Tang P., Chan H.-K., and Raper J.A. How much particle surface corrugation is sufficient to improve aerosol performance of powder?. Pharm. Res. 22 (2005) 148-152
10. Chiou H., Li L., Hu T., Chan H.-K., Chen J.-F., and Yun J. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation. Int. J. Pharm. 331 (2007) 93-98
11. Coates M.S., Chan H.-K., Fletcher D.F., and Raper J.A. Influence of air flow on the performance of dry powder inhaler using computational and experimental analyses. Pharm. Res. 22 (2005) 1445-1453
12. Columbano A., Buckton G., and Wikeley P. A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy. Int. J. Pharm. 237 (2002) 171-178
13. Columbano A., Buckton G., and Wikeley P. Characterisation of surface modified salbutamol sulphate-alkylppolycoside microparticles prepared by spray drying. Int. J. Pharm. 253 (2003) 61-70
14. Corrigan D.O., Corrigan O.I., and Healy A.M. Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems. Int. J. Pharm. 273 (2004) 171-182
15. Corrigan D.O., Healy A.M., and Corrigan O.I. Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates. Eur. J. Pharm. Biopharm. 62 (2006) 295-305
16. Corrigan D.O., Corrigan O.I., and Healy A.M. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers. Int. J. Pharm. 322 (2006) 22-30
17. Dhumal R.S., Biradar S.V., Paradkar A.R., and York P. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery. Int. J. Pharm. 368 (2009) 129-137
18. Education G.C. Quantitation Methods in Gas Chromatography (1998), GC Education, Alltech Associates Inc.
19. Fages J., Lochard H., Letourneau J.-J., Sauceau M., and Rodier E. Particle generation for pharmaceutical applications using supercritical fluid technology. Powder Technol. 141 (2004) 219-226
20. Gallagher P.M., Coffey M.P., Krukonis V.J., and Klasutic N. Gas antisolvent recrystallization: new process to recrystallize compounds insoluble in supercritical fluids. ASC Symposium Series 406 (1989), American Chemical Society, Washington, DC
21. Hamasaki K., Kato K., Watanabe T., Yoshimura Y., Nakazawa H., Yamamoto A., and Matsunaga A. Determination of l-menthol in pharmaceutical products by high performance liquid chromatography with polarized photometric detection. J. Pharm. Biomed. Anal. 16 (1998) 1275-1280
22. Hancock B., and Zografi G. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm. Res. 11 (1994) 471-477
23. Hu T., Chiou H., Chan H.-K., Chen J.-F., and Yun J. Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation. J. Pharm. Sci. 97 (2008) 944-949
24. Langrish T.A.G. Assessing the rate of solid-phase crystallization for lactose: the effect of the difference between material and glass-transition temperature. Food Res. Int. 41 (2008) 630-636
25. Malcolmson R.J., and Embleton J.K. Dry powder formulation for pulmonary delivery. Pharm. Sci. Technol. Today 1 (1998) 394-398
26. Najafabadi A.R., Vatanara A., Gilani K., and Tehrani M.R. Formation of salbutamol sulphate microparticles using solution enhanced dispersion by supercritical carbon dioxide. DARU 13 (2005) 1-5
27. Narishetty S.T.K., and Panchagnula R. Effect of l-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine. J. Control. Release 102 (2005) 59-70
28. Palakodaty S., and York P. Phase behavioural effects on particle formation process using supercritical fluids. Pharm. Res. 16 (1999) 976-985
29. Patel T., Ishiuji Y., and Yosipovitch G. Menthol: a refreshing look at this ancient compound. J. Am. Acad. Dermatol. 57 (2007) 873-878
30. Patton J.S., Fishburn C.S., and Weers J.G. The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1 (2004) 338-344
31. Prime D., Atkins P.J., Slater A., and Sumby B. Review of dry powder inhalers. Adv. Drug Deliv. Rev. 26 (1997) 51-58
32. Raula J., Thielmann F., Kansikas J., Hietala S., Annala M., Seppala J., Lahde A., and Kauppinen E.I. Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with l-leucine. Pharm. Res. 25 (2008) 2250-2261
33. Roberts C.J., and Debenedetti P.G. Engineering pharmaceutical stability with amorphous solids. AlChE J. 48 (2000) 1140-2114
34. Roos Y.H. Glass transition-related physicochemical changes in foods. Food Technol. 49 (1995) 97-102
35. R.P.S.G.B. Clarke's Analysis of Drugs and Poisons (2006), Pharmaceutical Press, London
36. Saleki-Gerhardt A., Ahlneck C., and Zografi G. Assessment of disorder in crystalline solids. Int. J. Pharm. 101 (1994) 237-247
37. 2-assisted aerosolization. J. Pharm. Sci. 90 (2001) 785-797
38. Shariati A., and Peters C.J. Recent developments in particle design using supercritical fluids. Curr. Opin. Solid State Mater. Sci. 7 (2003) 371-383
39. Shekunov B.Y., and York P. Crystallization processes in pharmaceutical technology and drug delivery design. J. Cryst. Growth 211 (2000) 122-136
40. 2. J. Supercrit. Fluids 41 (2007) 1-9
41. Stanton L.A., Dehghani F., and Foster N.R. Improving drug delivery using polymers and supercritical fluid technology. Aust. J. Chem. 55 (2002) 443-447
42. 2 as antisolvent: from phase equilibria to products. Int. J. Chem. Reactor Eng. 5 (2007) 1-12
43. 2 adsorption isotherms and modified Frenkel-Halsey-Hill theory. Langmuir 7 (2003) 2632-2638
44. Thakur R., and Gupta R.B. Rapid expension of supercritical solution with solid cosolvent (RESS-SC) process: formation of griseofulvin nanoparticles. Ind. Eng. Chem. Res. 44 (2005) 7380-7387
45. Thi T.H.H., Danede F., Descamps M., and Flament M.-P. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate. Eur. J. Pharm. Biopharm. 70 (2008) 380-388
46. Tong H.H.Y., and Chow A.H.L. Control of physical forms of drug particles for pulmonary delivery by spray drying and supercritical fluid processing. KONA 24 (2006) 27-40
47. US Pharmacopeia 28, US Pharmacopoeial Convention, Rockville, MD, 2005, pp. 2322-2332.
48. Ward G.H., and Schultz R.K. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm. Res. 12 (1995) 773-779
49. Williams M.L., Landel R.F., and Ferry J.D. The temperature dependence of relaxation mechanisms in amorphous polymers and other glass-forming liquids. J. Am. Chem. Soc. 77 (1955) 3701-3707
50. Yang Z.-Y., Le Y., Hu T.-T., Shen Z., Chen J.-F., and Yun J. Production of ultrafine sumatriptan succinate particles for pulmonary delivery. Pharm. Res. 25 (2008) 2012-2018